4D Molecular Therapeutics

Trial and FDA signals

• New trial + clinical hiring Started a Phase 3 trial (NCT07867080, actual start Sep 18, 2026); since then posted 2 clinical-operations roles. ClinicalTrials.gov NCT07867080 (Sep 18, 2026)
  Evidence (1 event)

  • Sep 18, 2026 · ClinicalTrials.gov NCT07867080
    leadSponsor.name='4D Molecular Therapeutics'; phases=['PHASE3']; overallStatus=RECRUITING; startDateStruct={date:2026-09-18,type:ACTUAL}; studyFirstPostDate=2026-10-09; briefTitle='A Phase 3 Trial for Intravitreal Injection of 4D-150 in Adults With Diabetic Macular Edema (DME).'

Job counts as of Oct 18, 2026. All trial and FDA signals